BBP vs. SBIT
BBP (Virtus LifeSci Biotech Products ETF) and SBIT (Proshares Ultrashort Bitcoin ETF) are both exchange-traded funds - BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while SBIT is a Cryptocurrency fund tracking the Bloomberg Bitcoin Index (-200%). Both are passively managed. Over the past year, BBP returned 51.33% vs 98.77% for SBIT. Their -0.31 correlation means they have often moved in opposite directions in the past. BBP charges 0.79%/yr vs 0.95%/yr for SBIT.
Performance
BBP vs. SBIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBP achieves a 17.46% return, which is significantly lower than SBIT's 39.44% return.
BBP
- 1D
- -2.71%
- 1M
- -5.26%
- 6M
- 15.00%
- YTD
- 17.46%
- 1Y
- 51.33%
- 3Y*
- 19.80%
- 5Y*
- 13.17%
- 10Y*
- 11.65%
- ALL TIME*
- 12.15%
SBIT
- 1D
- 5.60%
- 1M
- -6.04%
- 6M
- 32.41%
- YTD
- 39.44%
- 1Y
- 98.77%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -42.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.01M | $1.06M | $1.01M | |
| $29.57M | $32.71M | $46.48M |
BBP vs. SBIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 17.46% | 33.15% | 6.57% |
SBIT Proshares Ultrashort Bitcoin ETF | 39.44% | -25.11% | -73.74% |
Correlation
The correlation between BBP and SBIT is -0.31, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.31 |
Correlation (All Time) Calculated using the full available price history since Apr 2, 2024 | -0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. SBIT — Risk / Return Rank
BBP
SBIT
BBP vs. SBIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Proshares Ultrashort Bitcoin ETF (SBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBP | SBIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.92 | ||
| Sortino ratioReturn per unit of downside risk | +1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.23 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 5.61 | 2.35 | +3.26 |
| Martin ratioReturn relative to average drawdown | 15.91 | 5.19 | +10.72 |
Loading charts...
Drawdowns
BBP vs. SBIT - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum SBIT drawdown of -91.35%. Use the drawdown chart below to compare losses from any high point for BBP and SBIT.
Loading charts...
Drawdown Indicators
| BBP | SBIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -91.35% | +47.03% |
Max Drawdown (1Y)Largest decline over 1 year | -9.41% | -47.94% | +38.53% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -37.77% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | — | — |
Current DrawdownCurrent decline from peak | -9.41% | -77.87% | +68.46% |
Average DrawdownAverage peak-to-trough decline | -11.90% | -69.07% | +57.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.31% | 21.67% | -18.36% |
Volatility
BBP vs. SBIT - Volatility Comparison
The current volatility for Virtus LifeSci Biotech Products ETF (BBP) is 8.02%, while Proshares Ultrashort Bitcoin ETF (SBIT) has a volatility of 18.09%. This indicates that BBP experiences smaller price fluctuations and is considered to be less risky than SBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | SBIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.02% | 18.09% | -10.07% |
Volatility (6M)Calculated over the trailing 6-month period | 19.16% | 67.10% | -47.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.07% | 88.65% | -64.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.42% | 96.10% | -69.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.34% | 96.10% | -68.76% |
BBP vs. SBIT - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is lower than SBIT's 0.95% expense ratio.
Dividends
BBP vs. SBIT - Dividend Comparison
BBP has not paid dividends to shareholders, while SBIT's dividend yield for the trailing twelve months is around 4.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
SBIT Proshares Ultrashort Bitcoin ETF | 4.03% | 0.52% | 1.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBP and SBIT have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIT has higher volatility (18.09%) compared to BBP (8.02%). In terms of maximum drawdown, BBP dropped -44.32% vs SBIT's -91.35%.
On 1-year performance, SBIT leads with 98.77% vs 51.33% for BBP. On fees, BBP is cheaper at 0.79% per year. On volatility, BBP has been the lower-risk option at 8.02%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, SBIT has performed better with a 98.77% return vs 51.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBP is cheaper with a 0.79% expense ratio, compared with 0.95% for SBIT.
SBIT has the higher dividend yield at 4.03%, compared with 0.00% for BBP.
BBP is categorized as Health & Biotech Equities, while SBIT is Cryptocurrency. BBP tracks LifeSci Biotechnology Products Index, while SBIT tracks Bloomberg Bitcoin Index (-200%). They also come from different issuers: Virtus and ProShares. Their fees differ too: 0.79% for BBP and 0.95% for SBIT.
BBP currently has the higher Sharpe Ratio (2.19 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and SBIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer